In situ Complementomics enables spatial complement activation profiling and identification of therapeutic targets across human tissues

Abstract Complement activation is increasingly recognized as a driver of inflammation in diverse human diseases, prompting the development of targeted inhibitors across the cascade. However, despite compelling preclinical evidence, clinical success has been inconsistent, highlighting the need for to